Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.94 USD | +1.98% | +1.64% | +225.03% |
Apr. 08 | Canaccord Genuity Adjusts Price Target on CervoMed to $65 From $50, Maintains Buy Rating | MT |
Mar. 29 | CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+225.03% | 202M | |
+4.81% | 111B | |
+12.13% | 105B | |
-12.55% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.59% | 16.96B | |
+4.17% | 13.7B | |
+37.03% | 12.45B |
- Stock Market
- Equities
- CRVO Stock
- News CervoMed Inc.
- Canaccord Genuity Starts CervoMed With Buy Rating, $50 Price Target